Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC

Olaf Holz (Hannover, Germany), Arne Gaida, Olaf Holz, Shirin Nahidi, Sven Schuchardt, Christoph Nell, Rembert Koczulla, Jens Hohlfeld

Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Session: Exhaled biomarkers in children and adults with airways disease
Session type: Poster Discussion
Number: 2086
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Olaf Holz (Hannover, Germany), Arne Gaida, Olaf Holz, Shirin Nahidi, Sven Schuchardt, Christoph Nell, Rembert Koczulla, Jens Hohlfeld. Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC. Eur Respir J 2015; 46: Suppl. 59, 2086

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016


Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Breathprint of severe allergic asthma with SPME-GC-MS Analysis of exhaled air volatile organic compounds(Ege University translational pulmonology research group [EgeTPAG])
Source: International Congress 2016 – Airway biomarkers
Year: 2016

Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015



Measuring exhaled hydrogen sulphide (eH2S) levels in asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016

Can exhaled volatile organic compounds predict asthma exacerbations in children?
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015

Do volatile organic compounds (VOCs) discriminate between eosinophilic and neutrophilic asthma phenotype?
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015


Hydrogen sulfide (H2S) in sputum and serum as a novel biomarker of COPD
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Volatile organic compounds (VOCs) in COPD patients with exacerbation
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Airborne concentration of limonene (a volatile organic compound (VOC)), when using a spray of 41 essential oils
Source: Annual Congress 2013 –Outdoor and indoor environment: respiratory diseases from asthma to asbestosis
Year: 2013

Hydrogen sulphide as a biomarker in COPD and asthma
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014


Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort
Source: Eur Respir J, 57 (2) 2002127; 10.1183/13993003.02127-2020
Year: 2021



Measurement of volatile organic compounds in exhaled breath of children of the ALL Age Asthma Cohort
Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Year: 2018



Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Source: Eur Respir J 2011; 38: 1301-1309
Year: 2011